We are a global research-based biopharmaceutical company. Our skills and resources are focused on discovering, developing and marketing medicines for some of the world’s most serious illnesses, including cancer, heart disease, neurological disorders such as schizophrenia, respiratory disease and infection.

As a global biopharmaceutical company, our activities touch many people’s lives.

For patients and physicians, we provide medicines for some of the world’s most serious diseases.

For the people who pay for healthcare, we work to make sure that our medicines offer real value for money.

For our employees, we provide a culture in which they can feel appreciated, energised and rewarded for their contribution.

For our shareholders, we aim to deliver value through our continued focus on innovation and running our business efficiently.

For the wider community, we want to be valued for the contribution our medicines can make to society and trusted for the way in which we do business.

We work closely with all these groups to gain the insights we need to maintain a flow of life-changing medicines that make a real difference for patients in the fight against disease and which add value for our stakeholders and society.